United States · Bill · HR
H.R. 8190 (116th)
Biosimilar Insulin Access Act of 2020
Introduced
8 September 2020
Last action
16 September 2020 · Introduced
Status
Sponsor introductory remarks on measure. (CR H4487)
Sponsors
Rep. Grothman, Glenn [R-WI-6], Michael San Nicolas
Subjects
Healthcare
Source updated
3 January 2025
Summary
Biosimilar Insulin Access Act of 2020 This bill establishes that, if the Food and Drug Administration (FDA) finds that an insulin is biosimilar to a reference product, the insulin shall be deemed interchangeable with the reference product. (A biological product is biosimilar to a reference product if the two products are highly similar and have no clinically meaningful differences; the reference product generally receives FDA approval first, but the biosimilar product is typically less expensive.) Under current law, a biological product that is biosimilar to a reference product may be deemed interchangeable with the reference product only if it meets additional requirements. Current law provides that interchangeable products may be substituted for each other without the prescriber's involvement.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
8 September 2020
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
8 September 2020
Introduced
Introduced in House
Source: IntroReferral
8 September 2020
Introduced
Introduced in House
Source: IntroReferral
16 September 2020
Introduced
Sponsor introductory remarks on measure. (CR H4487)
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in House · 8 September 2020 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 8 September 2020
Introduced in House (PDF)
Introduced in House · EN · 8 September 2020
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 8 September 2020
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Grothman, Glenn [R-WI-6] · R · Sponsor
- Michael San Nicolas · D · Cosponsor
- · hsif00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/8190
- Open data entity: https://api.congress.gov/v3/bill/116/hr/8190
- us · 116-hr-8190 · source updated 3 January 2025